Pregled bibliografske jedinice broj: 1158918
Teratoma growth retardation by HDACi treatment of the tumor embryonal source
Teratoma growth retardation by HDACi treatment of the tumor embryonal source // Cancers, 12 (2020), 11; 3416, 23 doi:10.3390/cancers12113416 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1158918 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Teratoma growth retardation by HDACi treatment of
the tumor embryonal source
Autori
Krasić, Jure ; Škara, Lucija ; Ulamec, Monika ; Katušić Bojanac, Ana ; Dabelić, Sanja ; Bulić-Jakuš, Floriana ; Ježek, Davor ; Sinčić, Nino
Izvornik
Cancers (2072-6694) 12
(2020), 11;
3416, 23
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
HDACi ; TGCT ; epigenetics ; cancer stem cells ; valproate ; Trichostatin A
Sažetak
Among testicular germ cell tumors, teratomas may often be very aggressive and therapy-resistant. Our aim was to investigate the impact of histone deacetylase inhibitors (HDACi) on the in vitro growth of experimental mouse teratoma by treating their embryonic source, the embryo-proper, composed only of the three germ layers. The growth of teratomas was measured for seven days, and histopathological analysis, IHC/morphometry quantification, gene enrichment analysis, and qPCR analysis on a selected panel of pluripotency and early differentiation genes followed. For the first time, within teratomas, we histopathologically assessed the undifferentiated component containing cancer stem cell-like cells (CSCLCs) and differentiated components containing numerous lymphocytes. Mitotic indices were higher than apoptotic indices in both components. Both HDACi treatments of the embryos-proper significantly reduced teratoma growth, although this could be related neither to apoptosis nor proliferation. Trichostatin A increased the amount of CSCLCs, and upregulated the mRNA expression of pluripotency/stemness genes as well as differentiation genes, e.g., T and Eomes. Valproate decreased the amount of CSCLCs, and downregulated the expressions of pluripotency/stemness and differentiation genes. In conclusion, both HDACi treatments diminished the inherent tumorigenic growth potential of the tumor embryonal source, although Trichostatin A did not diminish the potentially dangerous expression of cancer-related genes and the amount of CSCLC.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Nino Sinčić
(autor)
Lucija Škara
(autor)
Davor Ježek
(autor)
Ana Katušić Bojanac
(autor)
Sanja Dabelić
(autor)
Monika Ulamec
(autor)
Jure Krasić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus